Clinical efficacy of fractional CO 2 laser treatment for vaginal relaxation syndrome
10.3760/cma.j.issn.1671-0290.2020.03.014
- VernacularTitle:CO 2点阵激光治疗阴道松弛综合征的效果
- Author:
Zhaoyang LI
1
;
Wenting SONG
;
Yunyan DUAN
;
Ting ZHU
;
Yanting WANG
;
Lin GAO
Author Information
1. 第四军医大学西京皮肤医院，西安 710032
- From:
Chinese Journal of Medical Aesthetics and Cosmetology
2020;26(3):220-223
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the clinical efficacy and safety of fractional CO 2 laser for the treatment of vaginal relaxation syndrome. Methods:Twenty-one females with vaginal relaxation syndrome receiced between December 2016 and January 2017 in our department were treated for 3 times at 1 month interval with femilift fractional CO 2 laser. Vaginal palpation, vaginal squeeze pressure test, vaginal ultrasound, pelvic floor MRI, and Incontinence Questionnaire Short-Form (ICIQ-SF) assessments were performed at baseline and at post-treatment. Results:Significant improvement in female sexual dysfunction and stress urinary incontinence was especially seen based on patient＇s feelings after treatments. A noted progressive differences were observed in FSFI and vaginal pressure test, which were much higher after treatment than before treatment ( P<0.01). Moreover, in 13 cases suffering from mild to moderate stress urinary incontinence (SUI), fractional CO 2 laser treatment was associated with a significant improvement of ICIQ-SF scores ( P<0.01). All subjects successfully completed the study with no adverse events such as infections, bleeding and pain, etc. Conclusions:Fractional CO 2 laser treatment is an effective treatment for female sexual dysfunction and stress urinary incontinence caused by vaginal relaxation syndrome.
